Allogeneic chimeric antigen receptor T cells targeting B cell maturation antigen

被引：0
|
作者：
Dar, Henia [1 ]
Henderson, Daniel [1 ]
Padalia, Zinkal [1 ]
Porras, Ashley [1 ]
Mu, Dakai [1 ]
Maeng, Kyungah [1 ]
Police, Seshi [1 ]
Kalaitzidis, Demetrios [1 ]
Terrett, Jonathan [1 ]
Sagert, Jason [1 ]
机构：
[1] CRISPR Therapeut, Cambridge, MA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1540
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-Cells
    Shah, Urvi A.
    Smith, Eric L.
    CANCER JOURNAL, 2019, 25 (03): : 208 - 216
  • [2] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Tiantian Ma
    Jing Shi
    Huasheng Liu
    Annals of Hematology, 2019, 98 : 813 - 822
  • [3] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
    Ma, Tiantian
    Shi, Jing
    Liu, Huasheng
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 813 - 822
  • [4] Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells
    Friedman, Kevin M.
    Garrett, Tracy E.
    Evans, John W.
    Horton, Holly M.
    Latimer, Howard J.
    Seidel, Stacie L.
    Horvath, Christopher J.
    Morgan, Richard A.
    HUMAN GENE THERAPY, 2018, 29 (05) : 585 - 601
  • [5] Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
    Rujirachaivej, Punchita
    Siriboonpiputtana, Teerapong
    Luangwattananun, Piriya
    Yuti, Pornpimon
    Wutti-in, Yupanun
    Choomee, Kornkan
    Sujjitjoon, Jatuporn
    Chareonsirisuthigul, Takol
    Rerkamnuaychoke, Budsaba
    Junking, Mutita
    Yenchitsomanus, Pa-thai
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [6] Selectivity and specificity of engineered T cells expressing KITE-585, a chimeric antigen receptor targeting B-cell maturation antigen (BCMA)
    Adams, Gregor B.
    Feng, Jun
    Ghogha, Atefeh
    Mardiros, Armen
    Rodriguez, Ruben
    Spindler, Tassja J.
    Wiltzius, Jed
    Polverino, Tony
    CANCER RESEARCH, 2017, 77
  • [7] T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
    Ali, Syed Abbas
    Shi, Victoria
    Maric, Irina
    Wang, Michael
    Stroncek, David F.
    Rose, Jeremy J.
    Brudno, Jennifer N.
    Stetler-Stevenson, Maryalice
    Feldman, Steven A.
    Hansen, Brenna G.
    Fellowes, Vicki S.
    Hakim, Frances T.
    Gress, Ronald E.
    Kochenderfer, James N.
    BLOOD, 2016, 128 (13) : 1688 - 1700
  • [8] Chimeric Antigen Receptor T Cells for B-Cell Lymphoma
    Newcomb, Richard
    Jacobson, Caron
    CANCER JOURNAL, 2021, 27 (02): : 107 - 111
  • [9] Parkinsonism Associated with Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy
    Schneider, Sabine
    Aamodt, Whitley W.
    Pruitt, Amy A.
    Berger, Joseph R.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (12): : 1625 - 1628
  • [10] Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
    Timmers, Marijke
    Roex, Gils
    Wang, Yuedi
    Campillo-Davo, Diana
    Van Tendeloo, Viggo F., I
    Chu, Yiwei
    Berneman, Zwi N.
    Luo, Feifei
    Van Acker, Heleen H.
    Anguille, Sebastien
    FRONTIERS IN IMMUNOLOGY, 2019, 10
12345